ORIC Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEXTECH INVEST, LTD. | 11/14/2025 | 7.16 M | $85.95 M | 0.00% | 9.17% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 6.73 M | $80.74 M | 315.81% | 8.61% |
| VR ADVISER, LLC | 11/14/2025 | 6.60 M | $79.16 M | 0.00% | 8.44% |
| VIKING GLOBAL INVESTORS LP | 11/14/2025 | 6.57 M | $78.87 M | 0.00% | 8.41% |
| PFIZER INC | 11/13/2025 | 5.38 M | $64.52 M | 0.00% | 6.88% |
| BLACKROCK, INC. | 11/12/2025 | 5.28 M | $63.32 M | 29.39% | 6.75% |
| VANGUARD GROUP INC | 11/07/2025 | 4.65 M | $55.80 M | 48.82% | 5.95% |
| SR ONE CAPITAL MANAGEMENT, LP | 11/12/2025 | 4.51 M | $54.18 M | 0.00% | 5.78% |
| ALKEON CAPITAL MANAGEMENT LLC | 11/14/2025 | 4.50 M | $54.05 M | 0.00% | 5.77% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2025 | 4.12 M | $49.42 M | 0.00% | 5.27% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 3.64 M | $43.70 M | 304.96% | 4.66% |
| COLUMN GROUP LLC | 11/14/2025 | 3.54 M | $42.49 M | 0.00% | 4.53% |
| VIVO CAPITAL, LLC | 11/14/2025 | 3.13 M | $37.52 M | 0.00% | 4.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 2.87 M | $34.46 M | 3.92% | 3.68% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 2.62 M | $31.44 M | -8.09% | 3.35% |
| FMR LLC | 11/13/2025 | 2.53 M | $30.34 M | 2.35% | 3.24% |
| STATE STREET CORP | 11/14/2025 | 2.40 M | $28.85 M | 47.29% | 3.08% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 2.16 M | $25.91 M | 7.44% | 2.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.95 M | $23.39 M | 8.22% | 2.49% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 1.73 M | $20.75 M | 0.00% | 2.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.63 M | $19.57 M | 47.12% | 2.09% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.52 M | $18.23 M | -14.54% | 1.94% |
| ROYCE & ASSOCIATES LP | 11/12/2025 | 1.46 M | $17.50 M | 521.23% | 1.87% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.23 M | $14.74 M | -8.01% | 1.57% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.20 M | $14.38 M | -14.60% | 1.53% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.18 M | $14.18 M | 13.31% | 1.51% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 1.10 M | $13.17 M | -14.15% | 1.40% |
| SIREN, L.L.C. | 11/13/2025 | 1.01 M | $12.09 M | 0.00% | 1.29% |
| EUCLIDEAN CAPITAL LLC | 11/14/2025 | 989.41 K | $11.87 M | 0.00% | 1.27% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 951.51 K | $11.42 M | 0.01% | 1.22% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 904.81 K | $10.86 M | 84.79% | 1.16% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 900.00 K | $10.80 M | -28.00% | 1.15% |
| NORTHERN TRUST CORP | 11/14/2025 | 888.54 K | $10.66 M | 121.61% | 1.14% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 793.87 K | $9.52 M | 11.05% | 1.02% |
| MORGAN STANLEY | 11/14/2025 | 745.53 K | $8.95 M | 88.84% | 0.95% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 603.21 K | $7.24 M | 57.75% | 0.77% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 468.61 K | $5.62 M | 100.00% | 0.60% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 447.37 K | $5.37 M | 22.43% | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 431.69 K | $5.18 M | 9.37% | 0.55% |
| UBS GROUP AG | 11/13/2025 | 339.24 K | $4.07 M | 242.64% | 0.43% |
| SECTORAL ASSET MANAGEMENT INC | 11/14/2025 | 328.66 K | $3.94 M | 41.98% | 0.42% |
| WOODLINE PARTNERS LP | 11/14/2025 | 246.53 K | $2.96 M | 0.89% | 0.32% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 238.62 K | $2.86 M | 175.05% | 0.31% |
| NICHOLAS INVESTMENT PARTNERS, LP | 11/14/2025 | 220.74 K | $2.65 M | 197.32% | 0.28% |
| BARCLAYS PLC | 11/12/2025 | 184.09 K | $2.21 M | 29.02% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 175.71 K | $2.11 M | 30.13% | 0.22% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 171.93 K | $2.06 M | 0.29% | 0.22% |
| RESOLUTE CAPITAL ASSET PARTNERS LLC | 11/14/2025 | 167.52 K | $2.01 M | -26.37% | 0.21% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 166.46 K | $2.00 M | -17.09% | 0.21% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 151.70 K | $1.82 M | -14.63% | 0.19% |
ORIC Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 185 institutional investors and hedge funds held shares of ORIC Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Nextech Invest, Ltd.: 7.16 M
EcoR1 Capital, LLC: 6.73 M
VR Adviser, LLC: 6.6 M
VIKING GLOBAL INVESTORS LP: 6.57 M
PFIZER INC: 5.38 M
BlackRock, Inc.: 5.28 M
136.31% of ORIC Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 124.90 M shares in the last 24 months. This purchase volume represents approximately $1.44 B in transactions.